Enclomiphene: The TRT Alternative That Preserves Fertility

Your testosterone is low. Your doctor suggested TRT. And then someone mentioned — maybe a friend, maybe a Reddit thread — that TRT can make you infertile while you're on it.

So now you're looking at enclomiphene.

Good. You should be. If you want to raise your testosterone without shutting down your ability to have children, this is the conversation worth having. Enclomiphene works differently than testosterone replacement, and for men in their 30s who aren't done building their family, that difference matters enormously.

Here's what you actually need to know: how it works, what the clinical evidence shows, what it costs, and who it's right for.

What Is Enclomiphene?

Enclomiphene is a selective estrogen receptor modulator, or SERM. It blocks estrogen receptors in your hypothalamus and pituitary gland, the parts of your brain that regulate testosterone production. When those receptors get blocked, your brain reads the situation as "not enough estrogen" and responds by increasing GnRH, which triggers more LH and FSH, which tells your testes to make more testosterone.

Your body does the work. Enclomiphene just removes the brake.

It's the trans-isomer of clomiphene citrate (the compound most people know as Clomid). Clomid contains roughly 62% enclomiphene and 38% zuclomiphene. The zuclomiphene fraction is estrogenic, accumulates in the body, and is responsible for most of Clomid's side effects. Enclomiphene, isolated on its own, carries none of that baggage (Gupta, 2018).

This is why physicians who work with male hormones increasingly prefer enclomiphene to Clomid when they're using a SERM approach. You get the testosterone-boosting mechanism without the estrogenic interference.

How Does Enclomiphene Raise Testosterone?

Enclomiphene works through the hypothalamic-pituitary-gonadal (HPG) axis, the hormone signaling chain that runs from your brain to your testes. Within 14 days of starting treatment, men with low testosterone see measurable increases in serum testosterone (Wiehle et al., 2014).

The mechanism is straightforward: estrogen normally signals the hypothalamus to slow down testosterone production. Enclomiphene blocks that signal. Without the brake, the pituitary releases more LH and FSH. LH tells your Leydig cells to produce testosterone. FSH supports sperm production in the Sertoli cells.

In a 30-day study of healthy males, clomiphene administration (which delivers both isomers, with enclomiphene doing the heavy lifting) increased mean testosterone levels by 146%, LH by 177%, and FSH by 170% compared to baseline (Miller et al., 2019).

Men with existing secondary hypogonadism showed similar results. In one clinical study, patients on clomiphene citrate therapy went from a median total testosterone of 205 ng/dL to 488 ng/dL (more than doubling their levels), while LH and estradiol also increased significantly (Helo et al., 2017).

These numbers come from real clinical data, not supplement marketing.

Enclomiphene vs. TRT: The Key Difference

This is the question most men are actually asking when they search for enclomiphene.

Traditional testosterone replacement therapy (TRT) delivers testosterone from outside your body. Your brain detects that testosterone is already present, stops signaling your testes to produce more, and shuts down the HPG axis. LH and FSH drop toward zero. Sperm production, which depends on FSH, goes with them. Most men on TRT become functionally infertile while on it (Kaminetsky, 2009).

Enclomiphene does the opposite. It stimulates your brain to produce more LH and FSH, which then drives your testes to make more testosterone. The entire HPG axis stays active. Your sperm production doesn't just survive. It's actively supported by elevated FSH.

For a man who wants to optimize testosterone while keeping fertility intact — whether he's planning a family now or just wants to preserve optionality — this tradeoff is significant. TRT is highly effective at raising testosterone, but you're borrowing against your fertility while you're on it.

For a deeper look at the delivery methods available for testosterone therapy, see TRT delivery methods compared.

Is Enclomiphene FDA-Approved?

No. This is something every patient needs to understand clearly before starting.

Enclomiphene was developed by Repros Therapeutics under the brand name Androxal specifically for male secondary hypogonadism. The company went through Phase 3 clinical trials and submitted two New Drug Applications to the FDA, one in 2013 and one in 2015. Both were rejected. The FDA's concerns centered on cardiovascular safety data, insufficient long-term evidence, and questions about the study endpoints.

As of 2026, enclomiphene has no active FDA approval and no approved brand-name product in the United States.

What's available is compounded enclomiphene through 503A and 503B licensed compounding pharmacies, accessible only with a physician prescription (Rodriguez, 2016). This is legal, but it means you're not getting an FDA-reviewed product. You're getting a compounded formulation, and quality depends on the pharmacy your provider works with.

For context: clomiphene citrate (Clomid) is FDA-approved, but only for ovulatory dysfunction in women (NDA 012837). Off-label use of clomiphene in men is common medical practice, but that approval doesn't extend to male hypogonadism, and it doesn't apply to enclomiphene, which is a distinct compound.

The physician-guided pathway matters here. At HEXIS, we work with licensed compounding pharmacies and monitor your labs throughout. Compounded medication without proper monitoring isn't a protocol. It's a gamble.

Who Is Enclomiphene For?

Enclomiphene for men makes the most sense in specific situations. Hill et al. (2009) summarized the clearest clinical applications: men with secondary hypogonadism who need testosterone restoration without suppressing fertility. It's not right for everyone, and being honest about that is part of giving you useful information.

Good candidates:

Men with secondary hypogonadism, meaning the problem originates in the hypothalamus or pituitary, not the testes themselves. If your LH and FSH are low-normal and your testosterone is low, your signaling axis isn't doing its job. Enclomiphene can restart it (Kaminetsky, 2009).

Men who want to preserve fertility. This is the clearest clinical indication. If you're 32, your testosterone is 280 ng/dL, and you and your partner are trying to conceive, TRT would be the wrong choice. Enclomiphene is the right one.

Men who are not yet ready for TRT. Some patients want to try the least invasive approach first. If lifestyle optimization isn't enough and you want a therapeutic option that keeps your system running naturally, enclomiphene is worth trying before committing to lifelong TRT.

Less ideal candidates:

Men with primary hypogonadism, where the testes themselves are damaged or non-functional. If the problem is in your testes, no amount of LH signaling will fix it. Enclomiphene requires functional testicular tissue to work.

Men significantly above the normal testosterone range who want supraphysiological levels. Enclomiphene will raise your testosterone within the normal physiological range. It won't produce the dramatically elevated levels that exogenous TRT can.

If you haven't checked your labs yet, start there. A full panel gives you and your provider the data to make the right call. Our article on how to test testosterone levels covers exactly what to ask for.

Enclomiphene Dosing and Protocol

In clinical trials, the doses that showed efficacy were 12.5 mg and 25 mg daily (Earl, 2019). Compounding pharmacies formulate enclomiphene as oral capsules, typically in 12.5 mg increments.

Most providers start men at 12.5 mg daily and adjust based on lab response. Some patients do well at this dose long-term. Others need 25 mg to reach a meaningful therapeutic testosterone level.

Real-world results align with the clinical data. One commonly referenced Reddit case showed total testosterone rising from 260 ng/dL to 725 ng/dL on 12.5 mg daily over three months, accompanied by improvements in energy and anxiety. Estradiol also rose significantly (from 32.4 to 83.2 pg/mL), which is why lab monitoring matters.

Dosing should be individualized. Your response to enclomiphene depends on your baseline LH/FSH levels, testicular function, body composition, and age (Wiehle, 2013). There's no universal protocol. That's the point of working with a physician rather than sourcing it yourself.

Lab Monitoring on Enclomiphene

Because enclomiphene raises LH, FSH, and testosterone while also potentially increasing estradiol, you can't just take it and assume everything is fine. Lab monitoring is required.

Standard monitoring includes:

• Total and free testosterone — to confirm you're reaching therapeutic levels
• LH and FSH — to verify the mechanism is working as expected
• Estradiol (E2) — elevated estradiol can cause side effects including mood changes, nipple sensitivity, and fluid retention
• Complete blood count — to monitor hematocrit
• SHBG (sex hormone binding globulin) — relevant to calculating free testosterone

Initial labs typically happen 6-8 weeks after starting, with adjustments from there. If you're seeing low testosterone symptoms improve, that's a good sign. But labs confirm what symptoms suggest.

Enclomiphene Side Effects

The side effect profile of enclomiphene is generally milder than traditional Clomid because you're not dealing with the estrogenic zuclomiphene fraction. Wiehle et al. (2013) reported short-term clinical safety data for enclomiphene as satisfactory and comparable to testosterone gels and placebo. That said, side effects exist and are worth knowing.

The FDA's adverse event reporting database shows 769 total reports associated with enclomiphene (across all use cases), with the top-reported reactions including headache, hot flushes, nausea, mood changes, and anxiety. Most are consistent with the known mechanism: raising estrogen receptor activity in the brain while blocking estrogen's direct feedback effects.

Visual disturbances deserve specific mention. The clomiphene compound class has a well-documented association with visual symptoms (blurring, spots, and scintillating scotomata, or visual "flashes") that appear in the FDA's clomiphene label as a warning. These symptoms increase with higher doses and longer duration. If you experience visual changes on enclomiphene, contact your provider. For most patients, these don't occur at typical doses, but they can happen.

Elevated estradiol is the side effect to watch most carefully. Enclomiphene raises LH and FSH, which raises testosterone, and testosterone aromatizes into estradiol. If estradiol climbs too high, you may feel worse, not better: fatigue, mood swings, water retention, and reduced libido. This is why estradiol monitoring is non-negotiable, and why some patients benefit from a low-dose aromatase inhibitor alongside enclomiphene.

Enclomiphene and Athletes: WADA Prohibition

If you compete in any sport governed by WADA or USADA anti-doping rules, stop reading this section and talk to your sports physician before considering enclomiphene.

Enclomiphene is classified as a SERM and is prohibited under S4.2 (Anti-estrogenic substances) of the WADA 2024 Prohibited List — at all times, both in and out of competition. Clomiphene is explicitly named, and enclomiphene as the trans-isomer of clomiphene falls under this prohibition. There is no Therapeutic Use Exemption pathway for SERMs used for performance purposes.

Miller et al. (2019) specifically studied clomiphene's urinary detection window for anti-doping purposes and found the zuclomiphene isomer can be detectable in urine for 121 to over 261 days after use. Enclomiphene clears faster, but the detection window has not been fully characterized for all compounds in tested-sport contexts.

If you're a competitive athlete, this class of compounds is off limits. Full stop.

How Long Does Enclomiphene Take to Work?

Most men notice the first signs of response within 2-4 weeks: improved energy, better mood, sometimes sleep quality. These reflect the early testosterone response.

Lab-confirmed changes typically appear at 4-6 weeks, which is why most providers do a first follow-up panel around the 6-week mark. Wiehle et al. (2014) documented measurable serum testosterone increases within 14 days in their trial subjects.

Full response (stable testosterone levels, optimized dose, estradiol in a good range) usually takes 2-3 months of treatment and at least two rounds of labs. Some men find their sweet spot quickly. Others require more titration.

Cost, Coverage, and Getting Started

Enclomiphene is not FDA-approved, which means insurance typically won't cover it. It's dispensed through compounding pharmacies, and cost varies by pharmacy and dose.

Typical cost range: $75–$150 per month for compounded enclomiphene at standard doses, depending on the pharmacy and whether you're at 12.5 mg or 25 mg daily.

Insurance rarely covers compounded medications, especially for off-label hormone therapy. Health savings accounts (HSA) and flexible spending accounts (FSA) can typically be used for prescription compounded medications, which can offset costs.

Compare this to TRT: testosterone injections through a clinic typically run $100–$200 per month (some telehealth programs start lower), while topical gels can cost $200–$400 per month without insurance.

At HEXIS, your enclomiphene protocol starts with a complete hormone panel, not a brief intake form and a quick prescription. Your HEXIS provider reviews your LH, FSH, testosterone, estradiol, SHBG, and CBC before recommending any treatment. If enclomiphene is right for you, we'll prescribe it through a quality compounding pharmacy we trust and monitor your labs throughout your protocol.

Schedule a consultation if you want to know where your hormones actually stand and what your options are.